University of Bath   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Bath United Kingdom (1885)

Organization Overview

First Clinical Trial
2004
NCT00630747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bath and NE Somerset Primary Care Trust | Royal United Hospital Bath NHS Trust | Royal United Hospital NHS Trust, Bath, UK | Royal United Hospitals Bath NHS Foundation Trust | Royal United Hospitals Bath NHS FT | Royal University Hospital Foundation | The University of Bath in England | University of Bath

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Hemorrhage (Phase 3)

Infertility (Phase 4)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Parkinson Disease (Phase 3)

Postpartum Hemorrhage (Phase 3)

Respiratory Hypersensitivity (Phase 4)

Syndrome (Phase 3)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial APIs: 34